Resources

CAS COVID-19 Antiviral Candidate SAR Dataset

This open source dataset contains over 290K structure-activity relationship (SAR) data directed at COVID-19 protein, virus and disease targets reported in the literature, patents, and other public sources for over 9K of the substances included in the CAS COVID-19 Antiviral Candidate Compounds Dataset.

CAS COVID-19 Protein Target Thesaurus

The CAS COVID-19 Protein Target Thesaurus is a collection of the high-profile targets linked to SARS-CoV-2

CAS COVID-19 Dataset Properties

The CAS Covid-19 dataset has been extracted from the CAS REGISTRY® including known anti-viral drugs and related chemical compounds that are structurally similar to known antivirals and is subject to these license terms.

Global Science & Technology Trends Report - Therapeutic Fusion Protein R&D

With rapid advances in recombinant DNA and protein engineering technologies, therapeutic fusion proteins have emerged as a new option for biologics with improved pharmacokinetic stability and enhanced capability to act on molecular targets. Fusion proteins have also facilitated the development of new vaccines, and gene and cell therapy drugs to address other clinical challenges.

Global Science & Technology Trends Report: Gene and Cell Therapy R&D

This CAS white paper identifies major trends in gene and cell therapy R&D that may help to predict future developments and pinpoint opportunities for therapeutic applications in the treatment of various diseases.

Knowledge Management Training

Clean, well-managed data is essential for analytics and insights. CAS training can help you build a strong data foundation, to help prepare you for success.

Five Often Overlooked IP Gaps That Can Derail Your Innovation Strategy

Download this CAS whitepaper and learn five often overlooked IP gaps that can hinder innovation strategy.

CAS IP Research: Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D

This CAS whitepaper explores the transformation of IP and R&D, where organizations apply IP insights to accelerate breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.

iuvo BioScience Uses Improved Data to Accelerate Product Development for Clients